RLX Technology Inc vs GeneDx Holdings Corp — how do they compare? RLX Technology Inc trades at $2.03 (market cap $2.52B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: RLX Technology Inc is the larger of the two by market cap, and RLX Technology Inc pays a 4.85% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| RLX | WGS | |
|---|---|---|
Market Cap | $2.52B | $1.80B |
Sector | Technology | Technology |
52-Week High | $2.73 | $167.51 |
52-Week Low | $1.79 | $34.51 |
Enterprise Value | $1.15B | $1.80B |
Dividend Yield | 4.85% | — |
Trailing returns across standard periods
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →